October 2019 Vol 5 No 5
Many patients with cancer and cancer survivors suffer from pain and impaired functioning as a result of cancer treatment, even years after the treatment is over. Nevertheless, only a few people receive proper care to address these issues through cancer rehabilitation. Read More ›
Samantha Anderson refused to give up when her triple-negative breast cancer returned. Trusting her oncologist, she enrolled in the clinical trial with Tecentriq (atezolizumab) that led to the approval of the first immunotherapy for this type of breast cancer. Read More ›
There’s nothing funny about cancer, but the benefits of laughter are great even during cancer. Khevin Barnes uses his breast cancer diagnosis to bring the healing power of humor to others. Read More ›
An Interview with Stacie Lindsey, President, and Melinda Bachini, Advocacy Coordinator, Cholangiocarcinoma Foundation Read More ›
By Dan Dean
Until recently, the initial treatment for patients with CLL was chemotherapy alone. New targeted therapies are now available for use as the first treatment for CLL. At the 2019 ASCO meeting, 2 experts discussed the benefits of these new treatments. Read More ›
From well-intentioned friends and family members who share the latest rumor about cancer and nutrition to the crazy headlines on social media that are full of misinformation, people with cancer are barraged with advice—much of it bad. Registered Dietitian Julie Lanford busts 5 of those myths. Read More ›
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis. Read More ›